Back to results
US 2021/0087207 A1Published application
Process for preparing chiral 2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium compounds
AssigneeBASF SE
InventorsHarish SHINDE, Christopher KORADIN, Joachim DICKHAUT, Roland GOETZ, Eric George KLAUBER, Sukunath NARAYANAN, Dhanyakumar RAUT
Life of this patent
Estimating the term…
Abstract
The present invention relates to a process for preparing optically active compounds of formula X and intermediates thereof, wherein the variables of compound of formula X are as defined in the claims and the description.
Claims16
1-15. (canceled)
16:
- A process for preparing S-containing pyrimidinium compound of formula X
- wherein
- C* is an asymmetric carbon atom of S or R-configuration;
- R1 is C1-C4-alkyl, C3-C6-cycloalkyl, C2-C4-alkenyl, or —CH2-phenyl, which groups are unsubstituted or substituted with halogen or C1-C4-alkyl;
- R2 is a 5- or 6-membered saturated, partially unsaturated or aromatic carbo- or heterocyclic ring, wherein the ring is unsubstituted or substituted with R2a;
- Het is selected from D-1, D-2, and D-3:
- wherein
- Ra is each independently Ra is halogen, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, or phenyl;
- n is 0, 1 or 2;
- and
- # denotes the bond in formula X;
- R2a is halogen, C1-C6-haloalkyl, C1-C6-haloalkoxy, ORc, C(═O)ORc, C(═O)NRbRc, phenyl, or pyridyl, which is unsubstituted or substituted with halogen, C1-C6-haloalkyl or C1-C6-haloalkoxy;
- Rb is hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy;
- Rc is hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C6 cycloalkyl;
- wherein two geminally bound groups RcRb together with the atom to which they are bound, may form a 3- to 7-membered saturated, partially unsaturated or aromatic heterocyclic ring;
- comprising at least the step of,
- (E) reacting the compound of formula VII,
- wherein
- C* is an asymmetric carbon atom of S or R-configuration;
- Het is as defined in compound of formula X;
- with R1NCS, wherein R1 is C1-C4-alkyl, C3-C6-cycloalkyl, C2-C4-alkenyl or —CH2-phenyl, which groups unsubstituted or substituted by halogen or C1-C4-alkyl;
- in the presence of a base,
- to obtain a compound of formula VIII,
- wherein
- C* and Het are as defined in the compound of formula VII;
- R1 is as defined herein.
23 more elements
17:
- The process according to claim 16, further comprising at least the steps of,
- (A) reacting a compound of formula III,
- wherein
- W is halogen, O-p-toluenesulfonyl, O-methanesulfonyl, or O-trifluoromethanesulfonyl;
- Het is as defined in compound of formula X in claim 1;
- with M2ORAC wherein M2 is selected from lithium, sodium, potassium, aluminium, barium, caesium, calcium, and magnesium;
- RAC is C(═O)—C1-C4-alkyl;
- to obtain the compound of formula IV,
- wherein Het and RAC are as defined herein;
- (B) hydrolyzing the compound of formula IV as defined herein in the presence of an acid or a base to obtain a compound of formula V,
- wherein Het is as defined in compound of formula IV;
- (C) reacting the compound of formula V with X2SO2NH2 wherein X2 is halogen, to obtain the compound of formula VI
- wherein Het is as defined in compound of formula V;
- (D) hydrogenation of the compound of formula VI,
- in the presence of a hydrogenation catalyst MXLn(η-arene)m
- wherein
- M is a transition metal from group VIII to group XII of the periodic table;
- X is an anion;
- m is 0 or 1;
- Ln is Ln1 or Ln2,
- wherein
- Ln1 is a chiral ligand of the formula Ln1,
- wherein
- C* is an asymmetric carbon atom of S or R-configuration;
- R10 is OH or NH—SO2—R11;
- R11 is aryl unsubstituted or substituted independently of each other with halogen, C1-C10-alkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, SO3H, or SO3Na;
- or
- R11 is C1-C10-perfluoroalkyl, or R13R14N wherein R13 and R14 independently represent C1-C10-alkyl unsubstituted or substituted with C6-C10-aryl, or R13 and R14 each independently represent a C6-C10-cycloalkyl;
- R12 independently represents aryl ring or C6-C10-cycloalkyl ring, wherein the ring is unsubstituted or substituted independently of each other with halogen, C1-C10-alkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, SO3H, or SO3Na, or both R12 are linked together to form a 3- to 6-membered carbocyclic ring or a 5- to 10-membered partially unsaturated carbocyclic ring;
- Ln2 is a chiral phosphorous ligand;
- and a hydrogen source selected from a)hydrogen, b) mixture of N(R)3 wherein R is H or C1-C6-alkyl, and HCOOH, c) HCOONa or HCOOK, d) mixture of C1-C8-alcohol and t-BuOK, t-BuONa, or t-BuOLi, and e) combination of two or more from a) to d);
- to obtain a compound of formula VII,
- wherein
- C* is an asymmetric carbon atom of S or R-configuration;
- Het is as defined in compound of formula VI.
32 more elements
18:
- The process according to claim 16, further comprising the step (F) of reacting the compound of formula VIII with a compound of formula IX,
- wherein,
- LG is a leaving group selected from halogen, ORu, and SRu;
- wherein
- Ru is C1-C6-alkyl or aryl, which is unsubstituted or substituted with halogen;
- R2 is a 5- or 6-membered saturated, partially unsaturated or aromatic carbo- or heterocyclic ring, wherein the ring is unsubstituted or substituted with R2a;
- to obtain the compound of formula X.
4 more elements
19:
- The process according to claim 17, wherein η-arene is aryl ring which is unsubstituted or substituted with C1-C4-alkyl.
20:
- The process according to claim 17, wherein q-arene is selected from benzene, p-cymene, mesitylene, 1,3,5-triethylbenzene, hexamethylbenzene, anisole, 1,5-cyclooctadiene, cyclopentadienyl (Cp), norbornadiene, and pentamethylcyclopentadienyl (Cp*).
21:
- The process according to claim 17, wherein MXLn(η-arene)m in step (D) is MXLn1(η-arene)m and wherein R10 is NH—SO2—R11;
- and R12 and R11 independently are phenyl which are unsubstituted or substituted with 1 or 2 substituents selected from halogen, C1-C4-alkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, SO3H, and SO3Na.
22:
- The process according to claim 17, wherein MXLn(η-arene)m in step (D) is MXLn1(η-arene)m and wherein X is halide;
- R12 independently is phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl or 4-methoxyphenyl;
- R10 is NH—SO2—R11 and —SO2—R11 is p-toluenesulfonyl, methanesulfonyl, 4-benzenesulfonyl, or pentafluorophenyl-sulfonyl.
23:
- The process according to claim 17, wherein m is 1 and MXLn(η-arene)m in step (D) is of the formula MXLnCp*, wherein M is rhodium, ruthenium, iridium, palladium, iron, platinum, or nickel.
24:
- The process according to claim 17, wherein M in step (D) is rhodium, ruthenium, or iridium.
25:
- The process according to claim 16, wherein the base in step (E) is selected from triethylamine, diisopropylethyl amine, tri-nbutylamine, sodium hydroxide, and potassium hydroxide.
26:
- The process according to claim 16, wherein
- R1 is C1-C4-alkyl, C3-C6-cycloalkyl, or C2-C4-alkenyl, which is unsubstituted, or substituted with halogen.
27:
- The process according to claim 16, wherein
- R2 is phenyl, pyridinyl, or thiophenyl, which is unsubstituted or substituted by R2a.
28:
- The process according to claim 16, wherein
- Ra is halogen or C1-C4-haloalkyl.
29:
- The process according to claim 16, wherein Het is D-2 wherein n is 0 and Ra is halogen.
30:
- An optically active compound of formula VII
- wherein
- C* is an asymmetric carbon atom of S or R-configuration;
- and wherein Het is D-2 or D-3 as defined in claim 16.
1 more element